Mitochondria-Targeted Drug Development Digital Summit
April 27 - 29, 2021 - KS USHanson Wade
info@hansonwade.com
Phone:+ 1 415 735 3289
The Mitochondria-Targeted Drug Development Digital Summit is the only industry-led meeting focused on end-to-end mitochondria-targeting. Explore success stories from leading experts overcoming common challenges whilst exploring what's next to help you accelerate your pipeline into the clinic. With 20+ hours of content, 2 interactive workshops and over 5 hours of networking with key industry leaders from Larimar Therapeutics, Minovia Therapeutics, Mitokinin and many more, this comprehensive forum will completely focus on mitochondria-targeting drug development and the current challenges and opportunities in the field. Make this your 2021 must-attend meeting and network with 80+ senior CSOs, CEOs, research scientists, academics and investors committed to targeting mitochondria to tackle challenges with Mitochondrial and Age-related Diseases. Join Stealth BioTherapeutics, Cohbar, GenSight Biologics, Minovia Therapeutics and MISSION Therapeutics and many more, as they discuss how to best optimize and improve the persistence and durability of effective and scalable mitochondrial therapies this is a conversation not to miss. In this focused summit, you'll learn from the field's pioneers who'll be sharing their experience in: * Exploring the role of mitochondrial dysfunction in age-related diseases and rare genetic mitochondrial diseases * Examining early discovery and research findings * Evaluating preclinical drug development and studies * Discovering the patient perspective to aid mitochondria-targeted drug development * Assessing clinical development and showcasing current trials * Lessons learned from clinical trial design and how design can be improved to mitigate common challenges * Realizing the use of gene therapy, editing technology and innovation Incorporating insights from leading academics and pioneering biotech, uncover innovative research whilst gaining extensive technical knowledge on mitochondria-targeted therapies, this summit is your only and definitive meeting to examine the advancement of innovative therapies and drugs, focusing on the latest research in innovative targeting pathways, unique therapeutics, and new techniques to target mitochondrial dysfunction, whilst evaluating your clinical development landscape.